140 related articles for article (PubMed ID: 20549453)
1. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
Yamamoto F; Yamamoto H
Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):263-4. PubMed ID: 20549453
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
Tateishi A; Matsushita M; Asai T; Masuda Z; Kuriyama M; Kanki K; Ishino K; Kawada M; Sano S; Matsui H
Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):265-70. PubMed ID: 20549454
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
5. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Mozaffari MS; Schaffer SW
Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
[TBL] [Abstract][Full Text] [Related]
6. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
7. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
Deng H; Dokshin GA; Lei J; Goldsmith AM; Bitar KN; Fingar DC; Hershenson MB; Bentley JK
J Biol Chem; 2008 Apr; 283(15):10198-207. PubMed ID: 18252708
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
[TBL] [Abstract][Full Text] [Related]
10. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
Deres L; Bartha E; Palfi A; Eros K; Riba A; Lantos J; Kalai T; Hideg K; Sumegi B; Gallyas F; Toth K; Halmosi R
PLoS One; 2014; 9(7):e102148. PubMed ID: 25014216
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3beta and p70 ribosomal S6 kinase.
Deng H; Hershenson MB; Lei J; Anyanwu AC; Pinsky DJ; Bentley JK
Am J Physiol Lung Cell Mol Physiol; 2010 Jun; 298(6):L793-803. PubMed ID: 20190034
[TBL] [Abstract][Full Text] [Related]
12. GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.
Duran J; Oyarce C; Pavez M; Valladares D; Basualto-Alarcon C; Lagos D; Barrientos G; Troncoso MF; Ibarra C; Estrada M
PLoS One; 2016; 11(12):e0168255. PubMed ID: 27977752
[TBL] [Abstract][Full Text] [Related]
13. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
14. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes.
Kawasaki Y; Kugimiya F; Chikuda H; Kamekura S; Ikeda T; Kawamura N; Saito T; Shinoda Y; Higashikawa A; Yano F; Ogasawara T; Ogata N; Hoshi K; Hofmann F; Woodgett JR; Nakamura K; Chung UI; Kawaguchi H
J Clin Invest; 2008 Jul; 118(7):2506-15. PubMed ID: 18551195
[TBL] [Abstract][Full Text] [Related]
18. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
19. Regulation of β-catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop.
Jamieson C; Sharma M; Henderson BR
Traffic; 2011 Aug; 12(8):983-99. PubMed ID: 21496192
[TBL] [Abstract][Full Text] [Related]
20. 4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.
Gebhardt R; Lerche KS; Götschel F; Günther R; Kolander J; Teich L; Zellmer S; Hofmann HJ; Eger K; Hecht A; Gaunitz F
J Cell Mol Med; 2010 Jun; 14(6A):1276-93. PubMed ID: 19228266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]